Your browser doesn't support javascript.
loading
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273.
Dowell, Alexander C; Powell, Annabel A; Davis, Chris; Scott, Sam; Logan, Nicola; Willett, Brian J; Bruton, Rachel; Ayodele, Morenike; Jinks, Elizabeth; Gunn, Juliet; Spalkova, Eliska; Sylla, Panagiota; Nicol, Samantha M; Zuo, Jianmin; Ireland, Georgina; Okike, Ifeanyichukwu; Baawuah, Frances; Beckmann, Joanne; Ahmad, Shazaad; Garstang, Joanna; Brent, Andrew J; Brent, Bernadette; White, Marie; Collins, Aedin; Davis, Francesca; Lim, Ming; Cohen, Jonathan; Kenny, Julia; Linley, Ezra; Poh, John; Amirthalingam, Gayatri; Brown, Kevin; Ramsay, Mary E; Azad, Rafaq; Wright, John; Waiblinger, Dagmar; Moss, Paul; Ladhani, Shamez N.
Afiliación
  • Dowell AC; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Powell AA; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Davis C; Medical Research Council (MRC)-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
  • Scott S; Medical Research Council (MRC)-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
  • Logan N; Medical Research Council (MRC)-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
  • Willett BJ; Medical Research Council (MRC)-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
  • Bruton R; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Ayodele M; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Jinks E; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Gunn J; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Spalkova E; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Sylla P; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Nicol SM; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Zuo J; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Ireland G; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Okike I; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Baawuah F; University Hospitals of Derby and Burton National Health Service (NHS) Foundation Trust, Derby, United Kingdom.
  • Beckmann J; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Ahmad S; East London National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Garstang J; Manchester University National Health Service (NHS) Foundation Trust, Manchester, United Kingdom.
  • Brent AJ; Birmingham Community Healthcare National Health Service (NHS) Trust, Aston, United Kingdom.
  • Brent B; Nuffield Department of Medicine, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.
  • White M; University of Oxford, Oxford, United Kingdom.
  • Collins A; Nuffield Department of Medicine, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, United Kingdom.
  • Davis F; Department of General Paediatrics, Evelina London Children's Hospital, London, United Kingdom.
  • Lim M; The National Children's Hospital, Tallaght University Hospital, Dublin, Ireland.
  • Cohen J; Department of General Paediatrics, Evelina London Children's Hospital, London, United Kingdom.
  • Kenny J; Children's Neurosciences, Evelina London Children's Hospital at Guy's and St Thomas' National Health Service (NHS) Foundation Trust, King's Health Partners Academic Health Science Centre, London, United Kingdom.
  • Linley E; Department Women and Children's Health, School of Life Course Sciences (SoLCS), King's College London, London, United Kingdom.
  • Poh J; Department of Paediatric Infectious Diseases and Immunology Evelina London Children's Hospital, London, United Kingdom.
  • Amirthalingam G; Department Women and Children's Health, School of Life Course Sciences (SoLCS), King's College London, London, United Kingdom.
  • Brown K; Department of Paediatric Infectious Diseases and Immunology Evelina London Children's Hospital, London, United Kingdom.
  • Ramsay ME; United Kingdom (UK) Health Security Agency, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Azad R; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Wright J; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Waiblinger D; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Moss P; Immunisation and Vaccine Preventable Diseases Division, United Kingdom (UK) Health Security Agency, London, United Kingdom.
  • Ladhani SN; Bradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford, United Kingdom.
Front Immunol ; 13: 882515, 2022.
Article en En | MEDLINE | ID: mdl-35720281
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido